机译:表达PDGFB的MSCs改善了免疫缺陷小鼠中的人造血干细胞植入
Institute of Hematology and Blood Disease Hospital Chinese Academy of Medical Sciences and Peking;
Institute of Hematology and Blood Disease Hospital Chinese Academy of Medical Sciences and Peking;
Institute of Hematology and Blood Disease Hospital Chinese Academy of Medical Sciences and Peking;
Institute of Hematology and Blood Disease Hospital Chinese Academy of Medical Sciences and Peking;
Institute of Hematology and Blood Disease Hospital Chinese Academy of Medical Sciences and Peking;
Department of Medicine Loma Linda University;
STEMCELL TECHNOLOGIES;
Institute of Hematology and Blood Disease Hospital;
Institute of Hematology and Blood Disease Hospital;
Institute of Hematology and Blood Disease Hospital;
Institute of Hematology and Blood Disease Hospital;
Department of Medicine Loma Linda University;
State Key Laboratory of Experimental Hematology Institute of Hematology and Blood Disease Hospital;
机译:表达PDGFB的MSCs改善了免疫缺陷小鼠中的人造血干细胞植入
机译:表达PDGFB的间充质干细胞改善免疫缺陷小鼠的人造血干细胞植入(Vol 44,PG 312,2020)
机译:对CD34 +或谱系人脐带血供体造血干细胞/造血祖细胞的CD26抑制作用可改善长期植入NOD / SCID / Beta2null免疫缺陷小鼠的能力。
机译:瘦素片段增加造血干细胞群,提高其植入能力
机译:Leptin受体,一种高度植入长期功能造血干细胞的表面标志物的表面标志物
机译:表达PDGFB的间充质干细胞改善免疫缺陷小鼠的人类造血干细胞植入
机译:196:抗c-Kit靶向单克隆抗体ACK-2的能力靶向造血干细胞,并促进免疫缺陷小鼠中人CD34 +的植入和血淋巴的发育基于抗体的新型调节策略